Emerging advances in cancer nanotheranostics with graphene nanocomposites: opportunities and challenges
- PMID: 26252175
- DOI: 10.2217/nnm.15.68
Emerging advances in cancer nanotheranostics with graphene nanocomposites: opportunities and challenges
Abstract
As an inorganic nanomaterial, graphene nanocomposites have gained much attention in cancer nanotechnology compared with the other inorganic nanomaterial in recent times. Although a relatively new drug carrier, it has been extensively explored as a potential chemotherapeutic carrier and theranostic because of its numerous physicochemical properties, including, capability of multiple pay load, functionalization for drug targeting and photothermal effect. Despite potential benefit, its translation from bench to bed-side in cancer therapy is challenged due to its toxicity concern. Here, we discussed the present progress and future possibilities of graphene nanocomposites as a cancer theranostic. Moreover, the paper also exemplifies the effects of graphene/graphene oxide on tissues and organ functions in order to understand the extent and mechanism of toxicity.
Keywords: anticancer; biodistribution; cellular interaction; graphene; graphene oxide; in vitro in vivo toxicity; inorganic nanoparticle; nanotoxicity; theranostics.
Similar articles
-
Role of Graphene Nano-Composites in Cancer Therapy: Theranostic Applications, Metabolic Fate and Toxicity Issues.Curr Drug Metab. 2015;16(5):397-409. doi: 10.2174/1389200215666141125120633. Curr Drug Metab. 2015. PMID: 25429670 Review.
-
Nano-graphene in biomedicine: theranostic applications.Chem Soc Rev. 2013 Jan 21;42(2):530-47. doi: 10.1039/c2cs35342c. Chem Soc Rev. 2013. PMID: 23059655 Review.
-
Two dimensional carbon based nanocomposites as multimodal therapeutic and diagnostic platform: A biomedical and toxicological perspective.J Control Release. 2019 Aug 28;308:130-161. doi: 10.1016/j.jconrel.2019.07.016. Epub 2019 Jul 13. J Control Release. 2019. PMID: 31310783 Review.
-
Graphene oxide - A platform towards theranostics.Mater Sci Eng C Mater Biol Appl. 2017 Jul 1;76:1274-1288. doi: 10.1016/j.msec.2017.02.121. Epub 2017 Feb 27. Mater Sci Eng C Mater Biol Appl. 2017. PMID: 28482495 Review.
-
Graphene-based nanocomposites: synthesis and their theranostic applications.J Drug Target. 2018 Dec;26(10):858-883. doi: 10.1080/1061186X.2018.1437920. Epub 2018 Feb 26. J Drug Target. 2018. PMID: 29424250
Cited by
-
Nanotheranostic Applications for Detection and Targeting Neurodegenerative Diseases.Front Neurosci. 2020 Apr 30;14:305. doi: 10.3389/fnins.2020.00305. eCollection 2020. Front Neurosci. 2020. PMID: 32425743 Free PMC article. Review.
-
The Fractal Viewpoint of Tumors and Nanoparticles.Curr Med Chem. 2023;30(3):356-370. doi: 10.2174/0929867329666220801152347. Curr Med Chem. 2023. PMID: 35927901 Review.
-
Nanomedicine and versatile therapies for cancer treatment.MedComm (2020). 2022 Aug 18;3(3):e163. doi: 10.1002/mco2.163. eCollection 2022 Sep. MedComm (2020). 2022. PMID: 35992969 Free PMC article. Review.
-
Recent Advances in Nanomaterials-Based Chemo-Photothermal Combination Therapy for Improving Cancer Treatment.Front Bioeng Biotechnol. 2019 Oct 22;7:293. doi: 10.3389/fbioe.2019.00293. eCollection 2019. Front Bioeng Biotechnol. 2019. PMID: 31696114 Free PMC article. Review.
-
Redox-active nanomaterials for nanomedicine applications.Nanoscale. 2017 Oct 19;9(40):15226-15251. doi: 10.1039/c7nr05429g. Nanoscale. 2017. PMID: 28991962 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials